Aadi Bioscience, Inc. (AADI) Tops Q4 EPS by 5c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q4 EPS of ($0.60), $0.05 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.4 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy